Lisata Therapeutics, Inc. (LSTA) vs Lantern Pharma Inc. (LTRN)
A side-by-side comparison of Lisata Therapeutics, Inc. and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LSTA
Lisata Therapeutics, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
LTRN
Lantern Pharma Inc.
$1.00HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — LSTA vs LTRN
growth of $100 · dividends reinvested · last 6yLSTA -95.6% (-40.6%/yr)LTRN -93.7% (-36.9%/yr)LTRN compounded faster over this window
LSTA LTRN
LSTA vs LTRN: by the numbers
- •LTRN is the larger company ($13M vs $10M market cap).
- •Both run net losses; LTRN's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | LSTA | LTRN |
|---|---|---|
| P/S ratio | 103.81 | N/A |
| P/B ratio | 1.26 | N/A |
Profitability
| Metric | LSTA | LTRN |
|---|---|---|
| Gross margin | 14.12% | 0.00% |
| Operating margin | -10711.18% | 0.00% |
| Net margin | -14621.00% | 0.00% |
| ROE | -177.35% | N/A |
| ROIC | -204.32% | -358.04% |
Growth (annualized)
| Metric | LSTA | LTRN |
|---|---|---|
| Total return CAGR (5Y) | -40.75% | -37.05% |
Frequently asked
- How have LSTA and LTRN total returns compared?
- Over the past 5 years, LSTA delivered -40.75% and LTRN delivered -37.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.